Champions Oncology Inc

CSBR USD0.001
Create an alert
Sell$4.68
Buy$4.75
$0.06 (1.26%)
Last updated today at
Back to dashboard

Company Information

About this company

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Its pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development. The Company operates in one segment pertaining to oncology services. Its research platform is a proprietary bank of Patient Derived Xenograft (PDX) models. Its PDX models are deployed into advanced vivo and ex vivo pharmacology platforms, providing an insight into therapeutic programs. The PDX bank is characterized at the molecular, phenotypic and pharmacological levels, which provides a differentiated layer of data for its oncology dataset.

Key people

Ronnie Morris
Chairman of the Board
Robert Brainin
Chief Executive Officer, Director
David Miller
Chief Financial Officer
Joel Ackerman
Independent Director
Brian Alexander
Independent Director
Daniel N. Mendelson
Independent Director
David Sidransky
Independent Director
Scott R. Tobin
Independent Director
Click to see more

Key facts

  • Shares in issue
    14.04m
  • EPIC
    CSBR
  • ISIN
    US15870P3073
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $68.48m
  • Employees
    217
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.